QGel Competitors and Similar CompaniesClear all
QGel's competitors and similar companies include Nippon Chemiphar, PhaseBio Pharmaceuticals, Oasis Medical and Oxular.
 QGel QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics. |  Nippon Chemiphar Nippon Chemiphar is a pharmaceutical company that specializes in the development of generic drugs. |  PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. |  Oxular Oxular is an ophthalmic company developing drug and device combination treatments for retinal disease. | ||
Founding Date | Founding Date 2009 | Founding Date 1950 | Founding Date 2002 | Founding Date 1987 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Lausanne, CH HQ | Locations Chiyoda City, JP HQ Fukuoka, JP Osaka, JP Saitama, JP Sapporo, JP Sendai, JP | Locations Malvern, US HQ | Locations Glendora, US HQ San Dimas, US | Locations London, GB HQ |
Employees | Employees 147% decrease | Employees 887 | Employees 22 | Employees 1452% increase | Employees 4 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 34.7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥32.6b (FY, 2025) | Revenue (est.) $10.8m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ¥294m (FY, 2025) | Net income ($131.1m) (FY, 2021) | Net income N/A | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Nippon Chemiphar
HQ
Chiyoda City, JP
Employees
887
Nippon Chemiphar is a pharmaceutical company that specializes in the development of generic drugs.
View companyPhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View company
Oasis Medical
HQ
Glendora, US
Employees
145↑ 2% increase
OASIS Medical is a company that specializes in eye care solutions.
View companyOxular
HQ
London, GB
Employees
4
Oxular is an ophthalmic company developing drug and device combination treatments for retinal disease.
View company